Covalent Drug Discovery: Basic Principles and Analysis of Current Patent Literature
In this webinar, Philip Carpino, Ph.D., will discuss the basic principles of covalent drug discovery and will provide examples of targeted covalent modulators that have been approved by the Food and Drug Administration (FDA) or are in late-stage clinical trials. He will also summarize the diversity of warheads and will review the patent activity in this competitive space over the past few years.
Key takeaways
- The basic principles and advances in the field of covalent drug discovery
- The examples of targeted covalent modulators that have been approved by the FDA or are in late-stage clinical trials
- The patent activity in this competitive space over the past few years
Presented By:
Philip Carpino, Ph.D.